Skip to main content

Day: April 1, 2021

Idorsia veröffentlicht Ankündigung der ordentlichen Generalversammlung 2021

Allschwil, Schweiz – 1. April 2021 Idorsia Ltd (SIX: IDIA) veröffentlichte heute im Namen des Verwaltungsrates die formelle Ankündigung der kommenden ordentlichen Generalversammlung. Die Versammlung, an welcher der Geschäftsbericht per 31. Dezember 2020 verabschiedet wird, findet am Mittwoch, 12. Mai 2021, statt. Die Generalversammlung wird in Übereinstimmung mit der COVID-19-Verordnung 2, die vom Schweizer Bundesrat erlassen wurde, durchgeführt. Dies bedeutet, dass eine persönliche Teilnahme nicht möglich ist und die Abstimmung durch einen unabhängigen Stimmrechtsvertreter erfolgen wird. Mathieu Simon, Präsident des Verwaltungsrates, kommentierte:„Einmal mehr müssen wir der Gesundheit unserer Aktionäre und des Idorsia-Teams Vorrang einräumen, so dass wir nicht in der Lage sind, unsere Aktionäre zu einer persönlichen Versammlung einzuladen....

Continue reading

Press release Biocartis Group NV: Biocartis Announces Publication of 2020 Annual Report

PRESS RELEASE: REGULATED INFORMATION       1 April 2021, 07:00 CEST Biocartis Announces Publication of 2020 Annual Report Mechelen, Belgium, 1 April 2021 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the publication of its 2020 annual report. The 2020 annual report provides an overview of the figures and performance of Biocartis for the financial year ended 31 December 2020. The report is available as a PDF file and can now be downloaded here from the website of the Company. — END — More information:Renate DegraveHead of Corporate Communications & Investor Relations Biocartise-mail   rdegrave@biocartis.comtel         +32 15 631 729mobile   +32 471 53 60 64 About Biocartis Biocartis (Euronext Brussels: BCART) is an innovative...

Continue reading

Sodexo – Financial Report for First half Fiscal 2021

Financial Report for First half Fiscal 2021 available Issy-les-Moulineaux, April 1, 2021 Sodexo announces that its Financial report for the First half Fiscal 2021 is available online and filed with the Autorité des marchés financiers (AMF). This document is available on Sodexo’s website, www.sodexo.com, under “Regulated information” in the Finance section. It includes the condensed consolidated financial statements for the first half of Fiscal 2021, the First half activity report, the statement of responsibility for the First half financial report as well as the auditors’ report on the limited review of the above-mentioned financial statements. About Sodexo Founded in Marseille in 1966 by Pierre Bellon, Sodexo is the global leader in services that improve Quality of Life, an essential factor in individual and organizational performance....

Continue reading

Sodexo – Mise à disposition du Rapport financier semestriel 2020-2021

Mise à disposition du Rapport financier semestriel 2020-2021 Issy-les-Moulineaux, le 1er avril 2021 Sodexo annonce la mise en ligne ce jour et le dépôt auprès de l’Autorité des marchés financiers de son rapport financier semestriel portant sur le semestre clos le 28 février 2021. Le rapport financier semestriel peut être consulté sur le site internet de Sodexo, www.sodexo.com, rubrique « Finance / Information réglementée ». Il comprend les comptes consolidés résumés du premier semestre 2020-2021, le rapport semestriel d’activité, la déclaration du responsable du rapport financier semestriel ainsi que le rapport des commissaires aux comptes sur l’examen limité des comptes précités. À propos de Sodexo Créé en 1966 à Marseille par Pierre Bellon, Sodexo est le leader mondial des services pour améliorer la Qualité de Vie, facteur essentiel...

Continue reading

Deaglo & Brunel Partners announce strategic partnership to offer next generation FX risk management

Red Bank, NJ, UNITED STATES, March XX 2020 /EINPresswire.com/ – Deaglo today announced its partnership with Brunel Partners, a strategic consulting and capital raising firm that looks to identify and partner with unique investment opportunities and talented investment managers, predominantly in Latin America. “Since Deaglo launched we have been focused on building quality strategic alliances with the best-in-class placement agents across the globe” said Ashley Groves, Deaglo CEO. “Brunel Partners has relationships with some of the most exciting funds in Latin America and with the largest foreign investors investing into the region. Our goal is to help Brunel stabilize the impact of BRL volatility on their foreign investors returns and ultimately help their investment managers raise more capital overseas.” “We have seen the...

Continue reading

Frontier Announces Pricing of Initial Public Offering

DENVER, March 31, 2021 (GLOBE NEWSWIRE) — Frontier Group Holdings, Inc. (“Frontier”) today announced the pricing of its initial public offering of 30 million shares of its common stock at a price to the public of $19.00 per share. The offering consists of 15 million shares of common stock offered by Frontier and 15 million shares of common stock to be sold by certain of Frontier’s existing stockholders. A selling stockholder has granted the underwriters a 30-day option to buy an additional 4.5 million shares of common stock from such selling stockholder at the initial public offering price, less the underwriting discount and commissions. Frontier will receive net proceeds of approximately $266 million after deducting the underwriting discount and commissions and estimated offering expenses. Frontier will not receive any proceeds...

Continue reading

Horizonte Minerals Plc: Final Results for the Year Ended 31 December 2020

LONDON, April 01, 2021 (GLOBE NEWSWIRE) — Horizonte Minerals Plc, (AIM: HZM, TSX: HZM) (‘Horizonte’ or ‘the Company’) the nickel company focused on Brazil, announces its final results for the year ended 31 December 2020. Highlights:Strong cash position of £10.9 million as at 31 December 2020 maintained and supplemented post year end through a £18 million placing in February 2021. Significant progress made on the overall Project Finance package for the development of Araguaia. A syndicate of five international financial institutions mandated for a US$325 million senior debt facility to part fund the development of Araguaia. BNP Paribas, ING Capital LLC, Mizuho Bank, Ltd., Natixis (New York Branch), and Société Générale will act as the Mandated Lead Arrangers Non-binding, conditional term sheet agreed with one major cornerstone...

Continue reading

Analytica 宣佈將 PeriCoach® 骨盆健康解決方案擴展至中國

PeriCoach 將透過合資企業夥伴提供的產後護理中心、醫院、藥房連鎖店以及由該中心提供服務的網上平台等廣泛網絡展開分銷。 合資公司還將利用遍佈 100 個城市的 30,000 多名臨床醫生的廣泛網絡在中國分銷 PeriCoach。 協議建立在 Analytica 現有的中東分銷合作夥伴關係基礎上,以促進 PeriCoach 在國際市場上的增長與製造。 臨床試驗證實,無監督的 PeriCoach 治療可與用於治療壓力性尿失禁的臨床盆腔底物理治療媲美,而且成本更低。 PeriCoach 提供具成本效益的解決方案,以改善生活質素,減輕護理負擔並減少產後及老齡人口中隔尿墊的支出。澳洲布里斯班, April 01, 2021 (GLOBE NEWSWIRE) — 壓力性尿失禁專用的 PeriCoach 骨盆底運動系統澳洲製造商 Analytica Limited (ASX:ALT) 已與一家合資企業協議在中國、澳門、香港與台灣製造、分銷及推銷該系統。Analytica 與總部設在河北省的河北 NACOL Bio-Technology Co., Ltd (Nacol) 及石家莊的 Biosphere Pty Ltd (Biosphere) 合作。 Nacol 的主要股東包括河北愛能生物科技有限公司及石家莊億生堂醫用品有限公司, 兩家均為經驗豐富的中國醫療製造及分銷公司。 合資公司會在國家食品藥品監督管理總局 (CFDA) 將 PeriCoach 註冊為第 II 類醫療設備。隨著 CFDA 的批准,PeriCoach 可以成為處方治療,最初覆蓋地為華北地區的醫院網絡。 擴展到中國將支援 PeriCoach 分銷到迅速增長的產後康復市場及早期預防性高齡市場,因為全球三分之一的女性患有壓力性尿失禁。該協議進一步推動 Analytica 將 PeriCoach 推向全球市場的策略,與合作夥伴 Motion Egypt LLC 建立在中東的增長,並在中國以外的北美、歐洲和東南亞尋求其他合作夥伴。 PeriCoach...

Continue reading

Analytica annonce l’expansion de la solution de santé pelvienne PeriCoach® en Chine

PeriCoach sera distribuée via un vaste réseau de centres de soins post-partum, d’hôpitaux, de chaînes pharmaceutiques et de plateformes en ligne desservis par les partenaires de la coentreprise. La coentreprise s’appuiera également sur un vaste réseau de plus de 30 000 cliniciens dans 100 villes pour distribuer PeriCoach en Chine. Cet accord s’appuie sur le partenariat de distribution existant d’Analytica au Moyen-Orient pour faciliter la croissance et la fabrication de PeriCoach sur les marchés internationaux. L’essai clinique confirme que le traitement PeriCoach non supervisé est comparable à la physiothérapie du plancher pelvien en clinique pour le traitement de l’incontinence urinaire à l’effort, à un coût beaucoup plus faible. PeriCoach fournit une solution rentable pour améliorer la qualité...

Continue reading

Analytica kündigt Expansion der PeriCoach® Lösung für Beckengesundheit nach China an

PeriCoach wird über ein umfangreiches Netzwerk von postpartalen Versorgungszentren, Krankenhäusern, Apothekenketten und Online-Plattformen von Joint Venture-Partnern vertrieben. Darüber hinaus nutzt das Joint Venture ein umfangreiches Netzwerk von über 30.000 Ärzten in 100 Städten, um PeriCoach in China zu vertreiben. Die Vereinbarung baut auf der bestehenden Vertriebspartnerschaft von Analytica im Nahen Osten auf, die das Wachstum und die Herstellung von PeriCoach auf internationalen Märkten erleichtern soll. Eine klinische Studie bestätigt, dass die nicht überwachte PeriCoach-Behandlung gleichwertig ist mit der in Kliniken durchgeführten Beckenboden-Physiotherapie zur Behandlung von Belastungsinkontinenz, und das zu deutlich geringeren Kosten. PeriCoach bietet eine kostengünstige Lösung zur Verbesserung der Lebensqualität, zur Erleichterung...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.